Cytiva acquires CEVEC Pharmaceuticals, strengthening cell line development
Cytiva has acquired CEVEC Pharmaceuticals, a German provider of cell line development and viral vector manufacturing technologies.
Archives for October 6, 2022
Ginkgo Bioworks acquires circular RNA biotech Circularis
Ginkgo Bioworks is acquiring California biotech Circularis to strengthen its capabilities in cell and gene therapy.
Lecanemab trial 'pivotal' for other therapy developers targeting Alzheimer’s disease
The recent lecanemab trial read-out will have a sizeable impact on the path forward for other biopharma’s developing treatments for Alzheimer’s disease, says the chief executive of a company developing investigational therapies for rare peripheral...